Transitional Cell Carcinoma of Renal Pelvis
specificA carcinoma that arises from the urothelial lining of the renal pelvis. It is associated with tobacco use and usually presents with gross or microscopic hematuria. Urothelial carcinomas of the renal pelvis are usually of higher grade and higher stage compared to bladder urothelial carcinomas.
17
Centers
8
Active Trials
—
Cancer Funding
Top Centers for Transitional Cell Carcinoma of Renal Pelvis(17)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | NCI Comprehensive Active Research Program | 64.9 |
| 2 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 64.9 |
| 3 | NCI Clinical Active Research Program | 64.9 |
| 4 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program | 64.9 |
| 5 | University of Illinois Cancer CenterChicago, IL Active Research Program | 64.9 |
| 6 | Boston University Cancer CenterBoston, MA Active Research Program | 64.9 |
| 7 | Upstate Cancer CenterSyracuse, NY Active Research Program | 64.9 |
| 8 | Active Research Program | 64.9 |
| 9 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | 42.4 |
| 10 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive | 42.4 |
| 11 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive | 42.4 |
| 12 | NCI Comprehensive | 42.4 |
| 13 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive | 42.4 |
| 14 | Penn State Cancer InstituteHershey, PA | 42.4 |
| 15 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL | 42.4 |
| 16 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ | 42.4 |
| 17 | Loma Linda University Cancer CenterLoma Linda, CA | 42.4 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →